NASDAQ:NDRA | Free Cash Flow | ENDRA Life Sciences Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.12M
2025-12-31-$1.61M$0.00-$1.61M
2025-03-31-$1.29M$17,280.00-$1.31M
2024-12-31-$1.52M$0.00-$1.52M
2024-03-31-$2.14M$27,000.00-$2.17M
2023-12-31-$2.17M$6,884.00-$2.18M
2023-03-31-$2.51M$27,000.00-$2.53M
2022-12-31-$3.09M$38,563.00-$3.13M
2022-03-31-$3.1M$89,353.00-$3.19M
2021-12-31-$2.65M$0.00-$2.65M
2021-03-31-$2.92M$45,000.00-$2.97M
2020-12-31-$2.07M$64,850.00-$2.14M
2020-03-31-$3.09M$22,350.00-$3.11M
2019-12-31-$1.91M$38,357.00-$1.95M
2019-03-31-$2.54M$5,239.00-$2.55M
2018-12-31-$1.9M$0.00-$1.9M
2018-03-31-$2.45M$0.00-$2.45M
2017-12-31-$1.38M$0.00-$1.38M
2017-03-31-$236,274.00
2016-12-31-$546,164.00
2016-03-31-$53,757.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$5.18M$17,280.00-$5.2M
2024-12-31-$7.4M$16,000.00-$7.42M
2023-12-31-$9.55M$33,884.00-$9.58M
2022-12-31-$12.77M$202,577.00-$12.97M
2021-12-31-$11.12M$45,000.00-$11.17M
2020-12-31-$10.75M$75,333.00-$10.82M
2019-12-31-$8.59M$43,595.00-$8.63M
2018-12-31-$7.7M$100,000.00-$7.8M
2017-12-31-$3.3M$7,862.00-$3.31M
2016-12-31-$1.32M